Revision Techniques After Artificial Urinary Sphincter Failure in Men: Results From a Multicenter Study - 03/07/15
, Robert Chan b, Joel M. Vetter a, H. Henry Lai a, Timothy B. Boone b, Steven B. Brandes aAbstract |
Objective |
To compare the results of various single-component artificial urinary sphincter (AUS) revision techniques for continued/recurrent stress urinary incontinence (SUI). Although AUS placement for male SUI has a high rate of success, revisions may be performed for mechanical failure of an isolated component or continued/recurrent SUI.
Materials and Methods |
From 1993 to 2012, 90 AUS revisions including urethral cuff downsizing (19), pressure-regulating balloon replacement (18), cuff repositioning (11), or tandem cuff placement (42) were performed at 2 institutions. End points included reoperation, incontinence failure, and urethral erosion. The Kruskal-Wallis test was used to compare continuous variables, and the log-rank test was used to compare Kaplan-Meier curves.
Results |
Mean age was 70.2 years, and median follow-up was 33.6 months. Median time to revision was 28.9 months. Tandem cuff placement was associated with a lower rate of incontinence failure (P = .02), whereas cuff repositioning was associated with a higher rate of incontinence failure (P = .02). An increased rate of mechanical failure was observed with cuff downsizing (P = .01). Among options for revision (1) cuff downsizing is associated with a higher rate of mechanical failure, and (2) cuff repositioning with the same size is associated with a higher rate of incontinence failure, whereas (3) tandem cuff placement is associated with a lower rate of recurrent SUI compared to other types of AUS revision.
Conclusion |
Cuff repositioning is associated with an increased rate of persistent incontinence after AUS revision whereas tandem cuff placement is associated with a lower rate of recurrent or persistent incontinence.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: H. Henry Lai is a scientific study or trial investigator at Medtronic. Steven B. Brandes is a consultant at AMS. Timothy B. Brown is a scientific study/trial investigator at Novartis, EM Kinetics, and Astellas; is a consultant or advisor at Allergan, Astellas, and American Medical Systems; and is a meeting participant or lecturer at Allergan, Astellas, and American Medical Systems. Jairam R. Eswara, Robert Chan, and Joel M. Vetter have no relevant financial interests. |
Vol 86 - N° 1
P. 176-180 - juillet 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
